No Data
Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking
Earnings Preview: WVE to Report Financial Results Pre-market on November 12
$Wave Life Sciences(WVE.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $Wave Life Sciences(WVE.US)$ to post revenue of USD13.06M
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
B.Riley Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating, Raises Target Price to $22
Institutional Investors in Wave Life Sciences Ltd. (NASDAQ:WVE) See US$94m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Owning 46% Shares,institutional Owners Seem Interested in Wave Life Sciences Ltd. (NASDAQ:WVE),
No Data
No Data
